Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with psoriasis and obesity or ...

Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the landmark TOGETHER-PsO open-label Phase 3b ...

ScrollSticks: bibigo™ Creates Chopsticks that Let You Eat and Scroll at the Same Time

BLOOMINGTON, Minn., February 18, 2026--bibigo™, the brand behind America’s favorite TikTok dumplings, has just announced the launch of a chopstick made for the digital age. Following its online ...